Dataset related to article "Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome"
Authors/Creators
-
Luca castagna1
- Thomas Pagliardini2
- Stefania Bramanti1
- Jean Marc Schiano de Colella2
- Catalina Montes de Oca2
- Reda Bouabdallah2
- Jacopo Mariotti1
- Sabine Furst2
- Angela Granata2
- Chiara De Philippis1
- Samia Harbi2
- Barbara Sarina1
- FaezehLegrand2
- Valerio Maisano2
- Pierre Jean Weiller2
- Christian Chabannon2
- Carmelo Carlo-Stella1
- Armando Santoro3
- Didier Blaise2
- Raynier Devillier2
- 1. IRCCS Humanitas Research Hospital
- 2. Institut Paoli Calmettes
- 3. IRCCS Humanitas Research Hospital AND Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20072 Pieve Emanuele – Milan, Italy
Description
This record contains data related to article "Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome"
We report the outcome of 68 patients with advanced peripheral T-cell lymphoma receiving transplantation from haploidentical or from conventional donors. The 4-year OS, PFS, 2-year cumulative incidence of relapse and 2-year GRFS was 75%, 70%, 21%, and 51%, respectively. Survival was not affected by donor type. The 2-year NRM was 9%, lower after related or haploidentical donor (21% vs 0% vs 7%; p = 0.06). Grade 2-4 aGVHD cumulative incidence was significantly different after transplantation from haploidentical vs matched sibling vs unrelated donor, and (24% vs 35% vs 58%, p = 0.024). The familial donor cohort was compared to the unrelated cohort. Familial donor induced less grade 2-4 aGVHD, with a trend to less grade 3-4 aGVHD or moderate-severe cGVHD. The OS and PFS were not different, while the relapse risk and NRM were reduced. Allo-SCT is highly effective in T-cell lymphoma, with low NRM and low relapse rate. The incidence of aGVHD was lower after haploidentical transplantation. Related donor may challenge unrelated transplant reducing the risk of relapse and NRM
Files
Additional details
Related works
- Is supplement to
- 10.1038/s41409-020-01133-5 (DOI)
- 33191403 (PMID)